Impact of bivalirudin on outcomes after percutaneous coronary revascularization with drug-eluting stents Academic Article uri icon

Overview

MeSH Major

  • Angioplasty, Balloon, Coronary
  • Anticoagulants
  • Antithrombins
  • Coronary Disease
  • Heparin
  • Peptide Fragments
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Stents

abstract

  • Compared with heparin plus GP IIb/IIIa inhibition, routine use of bivalirudin as the procedural anticoagulant in contemporary PCI with drug-eluting stents was associated with lower rates of inhospital complications and similar long-term all-cause mortality.

publication date

  • October 2007

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.ahj.2007.06.023

PubMed ID

  • 17892994

Additional Document Info

start page

  • 695

end page

  • 701

volume

  • 154

number

  • 4